Oxehealth has announced another world first after the US Food and Drug Administration granted a De Novo clearance for its Oxehealth Vital Signs product.
RNS Investor Release
Oxehealth's Oxevision named one of 12 high impact innovations to join the NHS Innovation Accelerator in 2021.
We at Oxehealth are delighted to announce that we've been selected as one of the “First 100 Digital Health Companies” by Healthcare UK. The list was announced by Healthcare UK this morning.
Oxehealth is proud to have been included in the Department for International Trade's Digital Health Campaign - 'The First 100 Playbook'.